Amundi 13F: Adds $66M to CME Stake

Amundi Boosts CME Group Stake

Institutional investor Amundi grew its holdings in CME Group Inc. ticker CME on NasdaqGS during the period covered by its latest Form 13F filing with the SEC. The fund lifted its position by 13.7%, adding 250,780 shares to bring its total ownership to 2,075,107 shares. Based on market prices, the expanded stake carried an estimated value of $544.1 million.

CME Group Stock Context and Price Levels

Shares of CME Group traded near $262.18 as the broader market navigated shifting financial conditions. The stock sits below its 50-day moving average of $266.98 and remains under its 200-day moving average of $278.70. Over the past year, the company has seen prices move between a low of $218.31 and a high of $329.16.

Insider Buying and Selling at CME Group Inc.

Internal buying activity brought fresh attention to the exchange operator as multiple leaders added to their equity. On June 25, 2026, Timothy Bitsberger bought 645 shares at a price of $225.00 for a total value of $145,125. Daniel Kaye also purchased 645 shares on the same day at $225.00 per share, spending $145,125. Ford Harold Eugene JR. acquired 1,067 shares at $225.00 each, totaling $240,075. Additional purchases on June 25, 2026, included 645 shares bought by Tierney Robert JR for $145,125, 645 shares by Patrick Maloney for $145,125, and 645 shares by Bryan Durkin for $145,125.

Wall Street Analyst Views on CME

Analyst updates across autumn 2026 show varied perspectives on the exchange operator. On October 14, 2026, Wells Fargo maintained an Overweight rating and lifted its price target to $315.00 from $301.00. Morgan Stanley kept an Overweight rating on October 9, 2026, while moving its target to $337.00 from $330.00. Barclays maintained an Equal-Weight rating on October 7, 2026, with a target of $281.00. UBS kept a neutral stance on October 5, 2026, setting a target of $270.00, while TD Cowen reiterated a buy rating on October 5, 2026, with a $300.00 target. Earlier in October, Wells Fargo initiated coverage with an Overweight rating and a $301.00 target.

What CME Group Does

CME Group Inc. operates contract markets where participants trade futures and options on futures worldwide. The company provides clearing house services, financial data feeds, and execution venues for commodities, foreign exchange, and interest rate products. Institutional investors, professional traders, and corporations rely on these infrastructure services to manage financial risk.

Looking Ahead for Institutional Filings

Investors tracking major fund activity should remember that Form 13F filings look backward at holdings from a prior quarter and may not capture current trading positions. Market participants will also review upcoming earnings reports and further insider disclosures to gauge sentiment around the financial exchange operator.